Innovative Orthopedic Solutions ETEX Corporation specializes in developing and commercializing innovative calcium phosphate-based biomaterials for enhanced orthopedic clinical outcomes, presenting a sales opportunity for orthopedic clinics, hospitals, and healthcare providers seeking advanced bioresorbable bone substitute materials.
Expansion Potential With a focus on expanding applications through combinations with cells, biologics, and therapeutic agents, ETEX offers sales opportunities for companies in the biotechnology and life sciences sectors looking to collaborate on developing new products or treatment solutions.
Minimally Invasive Systems The delivery of ETEX's biomaterials in minimally invasive and user-friendly systems appeals to medical device manufacturers and healthcare institutions aiming to provide cutting-edge treatment options, creating potential sales avenues for partnerships and distribution agreements.
Niche Market Advantage As a leader in bioresorbable bone substitute materials, ETEX Corporation holds a competitive edge in a specialized market segment, offering sales opportunities for distributors and suppliers looking to tap into a high-value niche within the biotechnology and orthopedic industries.
Revenue Growth Potential Despite the current revenue range of $0-10M, ETEX's focus on developing advanced biomaterials and expanding its product applications indicates strong growth potential, making it an attractive prospect for investors, strategic partners, and organizations seeking long-term sales partnerships.
5K
$1B
153K$1B
10K$1B
64$10M
10K$1B
3K$1B
1.5K$100M$1B| Etex Corporation Email Formats | Percentage |
| FLast@etexcorp.com | 59% |
| First.Last@etexcorp.com | 29% |
| First@etexcorp.com | 6% |
| Last@etexcorp.com | 6% |
Biotechnology ResearchMassachusetts, United States11-50 Employees
Established in 1989, ETEX Corporation develops, manufactures and commercializes calcium phosphate-based biomaterials for improved orthopedic clinical outcomes. A leader in bioresorbable bone substitute materials, ETEX focuses on expanding applications through combinations with cells, biologics, or therapeutic agents delivered in minimally invasive and easy to use systems.
Company Overview
Funding & FinancialsEtex Corporation's revenue is in the range of $10M
Funding & FinancialsEtex Corporation's revenue is in the range of $10M
1-888-653-2347 
support@leadiq.com